The largest database of trusted experimental protocols

Ventana inform dual ish her2 kit

Manufactured by Roche
Sourced in Japan

The Ventana INFORM Dual ISH HER2 kit is a laboratory diagnostic tool designed for the detection of HER2 gene amplification in breast cancer tissue samples. It utilizes in situ hybridization (ISH) technology to provide a quantitative assessment of HER2 gene status.

Automatically generated - may contain errors

2 protocols using ventana inform dual ish her2 kit

1

Evaluating HER2 Expression in Paraffin Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin-embedded specimens were sectioned at a thickness of 3 μm and subjected to IHC and DISH. The HER-2 IHC was performed using the HercepTest II (Agilent Technologies, Santa Clara, CA) on an Autostainer Link 48 platform (Agilent Technologies) per the manufacturer's instructions. We outsourced the DISH to a clinical test company (BML, Kurume Laboratory, Saitama, Japan) and they performed DISH using a Ventana INFORM Dual ISH HER2 kit (Roche Diagnostics, Tokyo).
+ Open protocol
+ Expand
2

Immunohistochemical Biomarker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin blocks were stored in an environment with controlled temperature and humidity. For IHC, 4 μm sections were cut from each tissue block and stained with hematoxylin and eosin (HE). HE-stained slides were evaluated to select representative tumors and to verify high tumor content. The following antibodies were used for IHC: ER (SP1, rabbit monoclonal primary antibody CONFIRM, Roche Diagnostics, Tokyo, Japan), PgR (1E2, rabbit monoclonal primary antibody CONFIRM, Roche Diagnostics, HER2 (Dako HercepTest, Agilent Technologies, Tokyo, Japan), Ki-67 (MIB-1, Dako monoclonal mouse antibody, Agilent Technologies, Tokyo, Japan). Expression levels of ER and PgR were recorded using the Allred score [35 (link)]. Tumors scoring 3 or higher (corresponding to at least 1% positive cells) were considered positive for ER and PgR [17 (link), 36 (link)]. HER2 status was considered positive if membranous immunostaining was IHC 3+ or IHC 2+ and HER2 gene amplification was confirmed by dual color in situ hybridization using the Ventana Inform Dual ISH HER2 kit (Roche Diagnostics. Tokyo, Japan) [18 (link)]. The Ki-67 labeling index (LI) was calculated by dividing the number of Ki-67–positive tumor cells by the total number of tumor cells. High- and low-LI groups were separated using the mean Ki-67 LI as a cutoff [37 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!